Skip to main content
. Author manuscript; available in PMC: 2008 May 12.
Published in final edited form as: Drug Metab Dispos. 2006 Aug 23;34(11):1903–1908. doi: 10.1124/dmd.106.010249

Table 1.

Kinetic parameters for each enzyme/substrate combination.

Substrate Enzyme
Source
Km Vmax CLint
μM nmol/min/nmol
P450
ml/min/nmol
P450
Diclofenac Baculosomes® 5.1 ± 0.9 29 ± 2 5.7
Supersomes™ 2.6 ± 0.3 14.8 ± 0.4 5.7
RECO® 16 ± 2 16.8 ± 0.9 1.1
Reconstituted 30 ± 3 27 ± 1 0.9
HLMc 4.0 1670a 420b
(S)-Flurbiprofen Baculosomes® 16.2 ± 0.9 34 ± 1 2.1
Supersomes™ 21.6 ± 0.8 11.7 ± 0.8 0.54
RECO® 120 ± 10 16.8 ± 0.5 0.14
Reconstituted 45 ± 2 11.5 ± 0.2 0.25
HLMd 1.9 343 a 180 b
Tolbutamide Baculosomes® 103 ± 6 10.1 ± 0.2 0.098
Supersomes™ 194 ± 29 4.0 ± 0.2 0.021
RECO® 1462 ± 50 5.6 ± 0.1 0.0038
Reconstituted 220 ± 19 3.9 ± 0.1 0.018
HLMc 147 276 a 1.88 b
(S)-Warfarin Baculosomes® 4.6 ± 0.3 2.33 ± 0.03 0.51
Supersomes™ 13 ± 2 0.38 ± 0.01 0.029
RECO® 32 ± 2 0.698 ± 0.009 0.022
Reconstituted 52 ± 9 1.54 ± 0.07 0.030
HLMe 3.7 10.5a 2.8 b
a

Units of pmol/min/mg protein

b

Units of μl/min/mg protein